MedTrace Logo

IM Neostigmine for Accelerating Bladder Emptying After CS by Spinal Anesthesia

NCT04364607 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-06-07

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy of IM neostigmine (0.5 mg) for acceleration of bladder evacuation and prevention of postoperative urine retention following cesarean delivery carried out under spinal anesthesia

Conditions

  • Cesarean Section Complications

Interventions

DRUG

Neostigmine

Participants will receive 0.5 mg IM neostigmine

DRUG

NaCl 0.9%

Participants will receive IM NaCl 0.9% as a placebo

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Aml M Aljaml · Mansoura University

  • Mohamed A Elnegery, MD · Mansoura University

  • Nermeen M Shams-Eldien, MD · Mansoura University

  • Khalid Samir, MD · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-05
Primary Completion
2021-10-26
Completion
2021-10-26

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364607 on ClinicalTrials.gov